Shareholder Alert: Ademi LLP Investigates Whether Longboard Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public Shareholders

Ademi LLP is investigating Longboard (NASDAQ: LBPH) for possible breaches of fiduciary duty and other violations of law in its transaction with Lundbeck.

Click here to learn how to join our investigation or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

In the transaction, Longboard shareholders will receive only $60.00 per share in a tender offer that values the Longboard at approximately $2.6 billion equity value. The transaction agreement unreasonably limits competing transactions for Longboard by imposing a significant penalty if Longboard accepts a competing bid. Longboard insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of Longboard’s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

If you own Longboard common stock and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or here.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241014318513/en/